What Sonnet BioTherapeutics Holdings, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 14 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 250,265 |
| Disposed | 0 | 342,053 |
| Net activity | +0 | −91,788 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Bhatt Nailesh | Director | Dec 02 | Disposition to Issuer · D | −10,547 | — | — | 0 |
| Dexter Susan | Director | Dec 02 | Disposition to Issuer · D | −9,643 | — | — | 0 |
| Kenney Richard T | Chief Medical Officer | Dec 02 | Disposition to Issuer · D | −163,760 | — | — | 0 |
| Kenney Richard T | Chief Medical Officer | Dec 02 | Exercise / conversion · M | +163,760 | — | — | 163,760 |
| Kenney Richard T | Chief Medical Officer | Dec 02 | Disposition to Issuer · D | −69,614 | — | — | 0 |
| Kenney Richard T | Chief Medical Officer | Dec 02 | Withheld — tax / exercise cost · F | −16,891 | — | — | 69,614 |
| Kenney Richard T | Chief Medical Officer | Dec 02 | Exercise / conversion · M | +86,505 | — | — | 86,505 |
| Kenney Richard T | Chief Medical Officer | Dec 02 | Disposition to Issuer · D | −9,374 | — | — | 0 |
| Dyrness Albert D. | Director | Dec 02 | Disposition to Issuer · D | −4,537 | — | — | 0 |
| Cini John K. | Director | Dec 02 | Disposition to Issuer · D | −14,116 | — | — | 0 |
| McNeill Lori | Director | Dec 02 | Disposition to Issuer · D | −4,394 | — | — | 0 |
| Mcandrew Stephen J | Chief Business Officer | Dec 02 | Disposition to Issuer · D | −6,446 | — | — | 0 |
| Rao Raghu | Chief Executive Officer | Dec 02 | Disposition to Issuer · D | −22,356 | — | — | 0 |
| Griffith Donald J. | Chief Financial Officer | Dec 02 | Disposition to Issuer · D | −10,375 | — | — | 0 |
| Bhatt Nailesh | Director | Jul 11 | Grant / award · A | +10,000 | — | — | 10,547 |
| Cini John K. | Chief Scientific Officer | Jul 11 | Grant / award · A | +12,000 | — | — | 14,116 |
| Dexter Susan | Chief Technical Officer | Jul 11 | Grant / award · A | +8,000 | — | — | 9,643 |
| Rao Raghu | Interim CEO | Jul 11 | Grant / award · A | +20,000 | — | — | 22,356 |
| Griffith Donald J. | Chief Financial Officer | Jul 11 | Grant / award · A | +10,000 | — | — | 10,375 |
| McNeill Lori | Director | Jul 11 | Grant / award · A | +4,000 | — | — | 4,394 |
Loading...
